Skip to Main Content

Author Details

Daniel J Park
The University of Melbourne
1998
59
21
PMIDPaper TitleJournal TitlePublished Year
36103484Perish and publish: Dynamics of biomedical publications by deceased authors.PLoS One2022
33990632Genomic investigation of a dengue virus outbreak in Thiès, Senegal, in 2018.Sci Rep2021
34887416Population-based estimates of breast cancer risk for carriers of pathogenic variants identified by gene-panel testing.NPJ Breast Cancer2021
32338768Rare germline genetic variants and risk of aggressive prostate cancer.Int J Cancer2020
32060697Mismatch repair gene pathogenic germline variants in a population-based cohort of breast cancer.Fam Cancer2020
32772980Genetic testing in Poland and Ukraine: should comprehensive germline testing of <i>BRCA1</i> and <i>BRCA2</i> be recommended for women with breast and ovarian cancer?Genet Res (Camb)2020
31267764Hi-Plex2: a simple and robust approach to targeted sequencing-based genetic screening.Biotechniques2019
29351780FANCM and RECQL genetic variants and breast cancer susceptibility: relevance to South Poland and West Ukraine.BMC Med Genet2018
30326623sEst: Accurate Sex-Estimation and Abnormality Detection in Methylation Microarray Data.Int J Mol Sci2018
29422015Is RNASEL:p.Glu265* a modifier of early-onset breast cancer risk for carriers of high-risk mutations?BMC Cancer2018
29052111Targeted massively parallel sequencing characterises the mutation spectrum of PALB2 in breast and ovarian cancer cases from Poland and Ukraine.Fam Cancer2018
29224068Hi-Plex for Simple, Accurate, and Cost-Effective Amplicon-based Targeted DNA Sequencing.Methods Mol Biol2018
28063109Mutation screening of ACKR3 and COPS8 in kidney cancer cases from the CONFIRM study.Fam Cancer2017
28511696Variant effect prediction tools assessed using independent, functional assay-based datasets: implications for discovery and diagnostics.Hum Genomics2017
28825401A novel <i>Drosophila</i> injury model reveals severed axons are cleared through a Draper/MMP-1 signaling cascade.Elife2017
27083325UNDR ROVER - a fast and accurate variant caller for targeted DNA sequencing.BMC Bioinformatics2016
26541979Evaluation of germline BRCA1 and BRCA2 mutations in a multi-ethnic Asian cohort of ovarian cancer patients.Gynecol Oncol2016
26679037Global measures of peripheral blood-derived DNA methylation as a risk factor in the development of mature B-cell neoplasms.Epigenomics2016
27656414Fine resolution mapping of double-strand break sites for human ribosomal DNA units.Genom Data2016
27942458Single nucleotide-level mapping of DNA double-strand breaks in human HEK293T cells.Genom Data2016
27490804Genome-wide measures of DNA methylation in peripheral blood and the risk of urothelial cell carcinoma: a prospective nested case-control study.Br J Cancer2016
27539266Use of a Novel Nonparametric Version of DEPTH to Identify Genomic Regions Associated with Prostate Cancer Risk.Cancer Epidemiol Biomarkers Prev2016
25575445Mutation screening of PALB2 in clinically ascertained families from the Breast Cancer Family Registry.Breast Cancer Res Treat2015
25447460Hi-Plex targeted sequencing is effective using DNA derived from archival dried blood spots.Anal Biochem2015
25605578Abridged adapter primers increase the target scope of Hi-Plex.Biotechniques2015
24461215ROVER variant caller: read-pair overlap considerate variant-calling software applied to PCR-based massively parallel sequencing datasets.Source Code Biol Med2014
25050558Rare mutations in RINT1 predispose carriers to breast and Lynch syndrome-spectrum cancers.Cancer Discov2014
24493630A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.Cancer Epidemiol Biomarkers Prev2014
23497093The use of DNA from archival dried blood spots with the Infinium HumanMethylation450 array.BMC Biotechnol2013
24206657Hi-Plex for high-throughput mutation screening: application to the breast cancer susceptibility gene PALB2.BMC Med Genomics2013
23933242Cross-platform compatibility of Hi-Plex, a streamlined approach for targeted massively parallel sequencing.Anal Biochem2013
23931594A high-plex PCR approach for massively parallel sequencing.Biotechniques2013
23787919Tumour morphology predicts PALB2 germline mutation status.Br J Cancer2013
23809231COMPLEXO: identifying the missing heritability of breast cancer via next generation collaboration.Breast Cancer Res2013
23448497Prevalence of PALB2 mutations in Australasian multiple-case breast cancer families.Breast Cancer Res2013
23441864FAVR (Filtering and Annotation of Variants that are Rare): methods to facilitate the analysis of rare germline genetic variants from massively parallel sequencing datasets.BMC Bioinformatics2013
23535733Genome-wide association studies identify four ER negative-specific breast cancer risk loci.Nat Genet2013
2233145919p13.1 is a triple-negative-specific breast cancer susceptibility locus.Cancer Res2012
23366127Supercomputing enabling exhaustive statistical analysis of genome wide association study data: Preliminary results.Annu Int Conf IEEE Eng Med Biol Soc2012
22976474A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11.Hum Mol Genet2012
22464251Rare mutations in XRCC2 increase the risk of breast cancer.Am J Hum Genet2012
22267197Genome-wide association analysis identifies three new breast cancer susceptibility loci.Nat Genet2012
20512660No evidence of MMTV-like env sequences in specimens from the Australian Breast Cancer Family Study.Breast Cancer Res Treat2011
21858661FAN1 variants identified in multiple-case early-onset breast cancer families via exome sequencing: no evidence for association with risk for breast cancer.Breast Cancer Res Treat2011
20967614Enhanced solid phase PCR for increased loading of amplicon onto solid support.Methods Mol Biol2011
20967600Lariat-dependent nested PCR for flanking sequence determination.Methods Mol Biol2011
20091115Are PALB2 mutations associated with increased risk of male breast cancer?Breast Cancer Res Treat2010
21182766A PALB2 mutation associated with high risk of breast cancer.Breast Cancer Res2010
20463881Digital quantification of human eye color highlights genetic association of three new loci.PLoS Genet2010
18267099Enhanced solid phase PCR: mechanisms to increase priming by solid support primers.Anal Biochem2008
  • 1 - 50 of 59

Recommended Authors

Marta Gut
Universitat de Barcelona (UB)
Career Start Year 2010
Number of shared co-authors 5
Martin Kircher
Berlin Institute of Health (BIH) at Charite-Universitatsmedizin Berlin
Career Start Year 2008
Number of shared co-authors 0
Harmen J G van de Werken
Department of Immunology Erasmus University Medical Center
Career Start Year 2006
Number of shared co-authors 2
Max K??ller
KTH Royal Institute of Technology
Career Start Year 2003
Number of shared co-authors 0
Christie L Kovar
Baylor College of Medicine
Career Start Year 2002
Number of shared co-authors 4
Ian Bosdet
University of British Columbia
Career Start Year 2002
Number of shared co-authors 2
Brent S Pedersen
Center for Molecular Medicine, University Medical Center Utrecht
Career Start Year 2001
Number of shared co-authors 1
Chunlin Xiao
Chongqing Aier Eye Hospital
Career Start Year 2000
Number of shared co-authors 4
Nancy F Hansen
National Human Genome Research Institute, National Institutes of Health
Career Start Year 2000
Number of shared co-authors 1
Sarah J Wheelan
National Human Genome Research Institute, National Institutes of Health
Career Start Year 1998
Number of shared co-authors 0
Vineet Bafna
University of California San Diego
Career Start Year 1998
Number of shared co-authors 1
Jay Shendure
University of Washington
Career Start Year 1996
Number of shared co-authors 2
John V Pearson
QIMR Berghofer Medical Research Institute
Career Start Year 1996
Number of shared co-authors 18
Sean McGrath
Harvard T.H. Chan School of Public Health
Career Start Year 1996
Number of shared co-authors 0
Steven J M Jones
University of British Columbia
Career Start Year 1995
Number of shared co-authors 8
Belynda Hicks
Frederick National Laboratory for Cancer Research
Career Start Year 1994
Number of shared co-authors 51
Marco A Marra
University of British Columbia
Career Start Year 1993
Number of shared co-authors 7
Jean-Pierre A Kocher
Mayo Clinic
Career Start Year 1991
Number of shared co-authors 3
Ivo Gut
Spain Universitat de Barcelona (UB)
Career Start Year 1991
Number of shared co-authors 13
Aleksandar Milosavljevic
Baylor College of Medicine
Career Start Year 1991
Number of shared co-authors 1
Joakim Lundeberg
KTH Royal Institute of Technology
Career Start Year 1990
Number of shared co-authors 0
Donna M Muzny
Baylor College of Medicine
Career Start Year 1988
Number of shared co-authors 15
Elaine R Mardis
The Ohio State University
Career Start Year 1988
Number of shared co-authors 15
Richard A Gibbs
Baylor College of Medicine
Career Start Year 1987
Number of shared co-authors 15
Eivind Hovig
Center for Bioinformatics, University of Oslo
Career Start Year 1987
Number of shared co-authors 6
Jian-Bing Fan
Nanfang Hospital and Basic Medical College, Southern Medical University
Career Start Year 1987
Number of shared co-authors 5
Jiannis Ragoussis
McGill University
Career Start Year 1986
Number of shared co-authors 4
James C Mullikin
National Human Genome Research Institute, National Institutes of Health
Career Start Year 1985
Number of shared co-authors 4
David A Wheeler
Baylor College of Medicine
Career Start Year 1984
Number of shared co-authors 12
Richard K Wilson
The Ohio State University
Career Start Year 1983
Number of shared co-authors 2

Collaborators

Bernard J Pope
University of Melbourne, The University of Melbourne
Co-authored papers 26
Graham G Giles
Co-authored papers 22
David E Goldgar
University of Utah
Co-authored papers 10
Chol-Hee Jung
University of Melbourne
Co-authored papers 8
Roger L Milne
Co-authored papers 8
Esther M John
Co-authored papers 8
Irene L Andrulis
University of Toronto
Co-authored papers 7
Fergus J Couch
Mayo Clinic
Co-authored papers 6
Douglas F Easton
University of Cambridge
Co-authored papers 6
Javier Ben??tez
Instituto de Salud Carlos III
Co-authored papers 5
Paul D P Pharoah
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 5
Alison M Dunning
Co-authored papers 5
Andr?? G Uitterlinden
Erasmus University Medical Center
Co-authored papers 5
Per Hall
Co-authored papers 5
David J Hunter
The Kolling Institute, University of Sydney, and Royal North Shore Hospital
Co-authored papers 5
Jenny Chang-Claude
German Cancer Research Center (DKFZ)
Co-authored papers 5
Fernando Rivadeneira
University Medical Center Rotterdam
Co-authored papers 5
Peter A Fasching
Otto-Friedrich-University Bamberg
Co-authored papers 4
Montserrat Garcia-Closas
National Cancer Institute
Co-authored papers 4
Leslie Bernstein
Co-authored papers 4
Bertram M??ller-Myhsok
Max Planck Institute of Psychiatry
Co-authored papers 4
Jianjun Liu
Co-authored papers 4
Mary Beth Terry
Co-authored papers 4
Georgia Chenevix-Trench
QIMR Berghofer Medical Research Institute
Co-authored papers 4
Clare Turnbull
Institute of Cancer Research
Co-authored papers 4
Stephen J Chanock
National Cancer Institute, National Institutes of Health
Co-authored papers 4
Jonine D Figueroa
The Usher Institute, The University of Edinburgh
Co-authored papers 4
Børge G Nordestgaard
Co-authored papers 3
Nicholas G Martin
Co-authored papers 3
Vincent R Harley
Co-authored papers 3
Release 1.2